American Academy of Pain Management
BLUE RIBBON POSTER ABSTRACT PRESENTED BY PETER M. CARNEY, MD, AT THE ACADEMY’S 2014 CLINICAL MEETING
Introduction
The principles of the quantum theory (QT) offer an excit ing new treatment option for painful peripheral neuropathy (PPN), a devastating disease that affects an estimated 23 million Americans (1-4). Erwin Schrodinger, the Nobel Laureate and one of the founders of the quantum theory, proposed in 1943 chat “living matter at the cellular level can be thought of in terms of quantum mechanics-pure physics and chemistry (5).”
According to Hameroff and Penrose, “The term ‘quan tum’ refers to a discrete element of energy in a system, such as the energy E of a particle, or of some other subsystem, this energy being related to a fundamental frequency v of its oscillation, according to Max Planck’s famous formula (where h is Planck’s constant: E = hv). This deep relation berween discrete energy levels and frequency of oscillation underlies the wave/particle duality inherent in che quantum phenomenon…… The laws governing these submicroscopic
quantum entities differ from chose governing our everyday classical world. For example, quantum particles can exist in rwo or more states or locations simultaneously, where such
a multiple coexisting superposition of alternatives (each alternative being weighed by a complex number) would be described mathematically by quantum wave function (6).”
If we accept the concept that life is a molecular process that operates in accordance with quantum theory, then the more than 50 trillion living cells char make up a human being interact with all the quantum fields in their environ ment (1). “Cells and intracellular elements are capable of vibrating in a dynamic manner with complex harmonics, the frequency of which can now be measured and analyzed in a quantitative manner by Fournier analysis (7).” This has led to the concept of quantum resonance induction, which claims chat electrical currents and electromagnetic energy fields administered for pain treatment electronically induce and amplif), subatomic particle movements and activity to create healing within cells (l ).
Current evidence-based guidelines have established chat pregabalin, at doses of 600 mg/day, offers effective level A treatment for diabetic peripheral neuropathy (DPN) (8) because of two randomized controlled studies (9,l 0). In one study, at this dose level, 82 patients reduced their aver age VAS score by 2.4 points, 39% reduced their pain by at lease 50%, but at lease 38% had one or more adverse side effects (9). This has led experts in America to caution that the current treatments for DPN and PPN do not relieve pain completely in the majority of patients and most have significant adverse effects that the patient must be advised to expect (l l). In fact, European authorities have gone as far as to recommend that future investigations be targeted on new treatment options (12). Using the principles of physics rather than those of pharmacology offers such a new treatment option.